PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

HIG Capital completes recapitalisation of Navitas Life Sciences

An affiliate of HIG Capital (HIG) has completed the recapitalisation of Navitas Life Sciences (Navitas), a global technology-enabled clinical research organisation (CRO).

Navitas provides outsourced data science (including biostatistics, statistical programming, and data management), regulatory & safety services (including software and monitoring), and other full-service CRO capabilities to blue-chip large and mid-sized pharmaceutical and government clients. 

The Company’s functional service expertise optimises the clinical trial process, drives cost efficiencies for its clients, and ensures adherence to regulatory compliance requirements. The Company’s global operations span the United States, India, Europe and South America.
 

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured